| Effects of antibiotics on gut microbiota K Lange, M Buerger, A Stallmach, T Bruns Digestive Diseases 34 (3), 260-268, 2016 | 592 | 2016 |
| Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ... Gastroenterology 156 (5), 1368-1380. e10, 2019 | 412 | 2019 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 358 | 2020 |
| Adverse effects of biologics used for treating IBD A Stallmach, S Hagel, T Bruns Best practice & research Clinical gastroenterology 24 (2), 167-182, 2010 | 267 | 2010 |
| PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 74 (5), 1097-1108, 2021 | 201 | 2021 |
| Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study PJ Trivedi, WJ Lammers, HR Van Buuren, A Parés, A Floreani, ... Gut 65 (2), 321-329, 2016 | 198 | 2016 |
| Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease–a prospective multicenter observational study A Stallmach, C Langbein, R Atreya, T Bruns, A Dignass, K Ende, J Hampe, ... Alimentary pharmacology & therapeutics 44 (11-12), 1199-1212, 2016 | 174 | 2016 |
| Induction of innate immune memory via microRNA targeting of chromatin remodelling factors JJ Seeley, RG Baker, G Mohamed, T Bruns, MS Hayden, SD Deshmukh, ... Nature 559 (7712), 114-119, 2018 | 165 | 2018 |
| Risk factors and outcome of bacterial infections in cirrhosis T Bruns, HW Zimmermann, A Stallmach World journal of gastroenterology: WJG 20 (10), 2542, 2014 | 153 | 2014 |
| Etiologies and outcomes of acute liver failure in Germany J Hadem, F Tacke, T Bruns, J Langgartner, P Strnad, GU Denk, P Fikatas, ... Clinical gastroenterology and hepatology 10 (6), 664-669. e2, 2012 | 152 | 2012 |
| Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response PJ Trivedi, T Bruns, A Cheung, KK Li, C Kittler, T Kumagi, H Shah, ... Journal of hepatology 60 (6), 1249-1258, 2014 | 147 | 2014 |
| External ventricular drain infections: risk factors and outcome S Hagel, T Bruns, MW Pletz, C Engel, R Kalff, C Ewald Interdisciplinary perspectives on infectious diseases 2014 (1), 708531, 2014 | 124 | 2014 |
| Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis E Liaskou, LE Jeffery, PJ Trivedi, GM Reynolds, S Suresh, T Bruns, ... Gastroenterology 147 (1), 221-232. e7, 2014 | 120 | 2014 |
| Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure F Wong, S Piano, V Singh, M Bartoletti, R Maiwall, C Alessandria, ... Journal of hepatology 74 (2), 330-339, 2021 | 119 | 2021 |
| Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase CFM Perez, MH Harms, KD Lindor, HR Van Buuren, GM Hirschfield, ... Official journal of the American College of Gastroenterology| ACG 115 (7 …, 2020 | 106 | 2020 |
| A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients M Bartoletti, M Giannella, R Lewis, P Caraceni, S Tedeschi, M Paul, ... Clinical Microbiology and Infection 24 (5), 546. e1-546. e8, 2018 | 99 | 2018 |
| NOD2 gene variants are a risk factor for culture‐positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis T Bruns, J Peter, PA Reuken, DH Grabe, SR Schuldes, J Brenmoehl, ... Liver international 32 (2), 223-230, 2012 | 99 | 2012 |
| Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome MH Harms, WJ Lammers, D Thorburn, C Corpechot, P Invernizzi, ... Official journal of the American College of Gastroenterology| ACG 113 (2 …, 2018 | 96 | 2018 |
| Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity PJ Trivedi, T Bruns, S Ward, M Mai, C Schmidt, GM Hirschfield, CJ Weston, ... Journal of autoimmunity 68, 98-104, 2016 | 91 | 2016 |
| Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study) C Engelmann, A Herber, A Franke, T Bruns, P Reuken, I Schiefke, ... Journal of Hepatology 75 (6), 1346-1354, 2021 | 88 | 2021 |
Andreas Stallmach在 med.uni-jena.de 的电子邮件经过验证
